I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 6 studies | 23% ± 8% | |
| ciliated cell | 6 studies | 28% ± 8% | |
| endothelial cell | 5 studies | 27% ± 10% | |
| epithelial cell | 5 studies | 39% ± 19% | |
| hematopoietic precursor cell | 4 studies | 25% ± 7% | |
| CD4-positive, alpha-beta T cell | 4 studies | 20% ± 2% | |
| classical monocyte | 4 studies | 23% ± 6% | |
| natural killer cell | 4 studies | 19% ± 2% | |
| plasmacytoid dendritic cell | 4 studies | 23% ± 6% | |
| conventional dendritic cell | 3 studies | 28% ± 10% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| non-classical monocyte | 3 studies | 23% ± 6% | |
| pericyte | 3 studies | 21% ± 4% | |
| type I pneumocyte | 3 studies | 24% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| dendritic cell | 3 studies | 36% ± 9% | |
| intestinal crypt stem cell | 3 studies | 19% ± 1% | |
| basal cell | 3 studies | 33% ± 12% | |
| connective tissue cell | 3 studies | 21% ± 4% | |
| hematopoietic stem cell | 3 studies | 19% ± 4% | |
| memory B cell | 3 studies | 15% ± 0% | |
| regulatory T cell | 3 studies | 17% ± 2% |
